Compound class:
Synthetic organic
Comment: This compound is a potent and selective inhibitor of the cancer therapeutic target, phosphoinositide-3-kinase α (PI3Kα) [1]. It is orally bioavailable and has a long half-life (>10h), and it mediates an anti-gastric cancer effect in vivo.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
By biochemical assessment, compound 27 is selective for PIK3α compared to the other PI3Ks (~30-fold on average), and in a screening panel of 370 other kinases [1]. |
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|